Skip to main content
. 2021 Dec 23;12:775172. doi: 10.3389/fphys.2021.775172

Table 1.

Patient demographics and clinical scores.

# Site Sex Mutation site Age Dev. delay Epilepsy (Seizure type) Current medication Neurological features Motor development Language development Neuropsychiatric features GMFCS MACS CFCS
1 IT m c. 1702 + 1 G > C 2 years 10 months y y (tonic, myoclonic, and monthly clusters) None Axial and distal hypotonia; tremor Some steps with assistance No Autistic features; higher pain threshold IV IV IV
2 IT m Deletion exon 4&5 5 years 6 months y y (focal, tonic, and no clear triggers) TPM, PB, and CBD oil. CLB when needed Hypotonia, dystonia; buccal dyspraxia, hyporeflexia Not able to walk No Autistic features; lower pain threshold V V V
3 IT m c. 704 G > A
p. Arg235Gln
8 years 3 months y y (seizure-free since 6 months) None Mild tremor, ataxia Able to walk No Autistic features, bruxism II IV IV
4 NL m c. 579–3 C > G 10 years 6 months y n n/a Hypotonia; tremor after waking up Stereotypies; very active II III IV
5 NL m c. 620 A > G
p. Asp207Gly
6 years 3 months y n n/a Tremor Able to walk Diagnosed ASD; easily distracted I I II
6 NL m c. 1216 C > T
p. Arg406Cys
3 years 5 months y n n/a Hypotonia, ataxia, balance problems. Babinski sign, dysmetria Unable to walk, No IV n/a IV
7 NL m c. 847 G > A
p. Glu283Lys
7 years 6 months y y (tonic–clonic, focal, and tonic) LTG Dyspraxia, very moveable; tremor, ataxia Able to walk with support, Able to speak (correct grammar) Autistic features, highly (sensory) sensitive; restless; loses concentration rapidly; regression after seizure clusters I II III
8 NL m c. 227 T > C
p. Leu76Pro
3 years 4 months y n n/a Babinski sign, able to grab objects, Autistic features IV n/a V
9 DK f c.1651C > T
p. Arg551Cys
14 years y y (spasms, FIAS, tonic, and tonic–clonic) CBZ, LEV, and VNS Axial hypotonus, hypertonus Unable to walk No Profound ID V V V
10 DK f c.794 + 5G > A 8 years y y (FIAS, tonic, and tonic–clonic) RFM, LTG, CLB, and VNS Ataxia, poor coordination, hypotonia, oral dyspraxia Able to walk No Autistic features II IV III
11 DK f c.1387G > T p.Glu463* 14 years y y PER, VPA, CLB, and VNS n/a Able to walk n/a n/a n/a
12 DK m c.1437-6_1559delinsAT 10 years y y (spasms, FIAS, clonic, tonic-myoclonic, tonic–clonic, and SE) CLB, LAC, and VNS Spastic tetraparesis, hypotonia, dyskinesia Unable to walk No Severe/profound ID V V V
13 DK m c.795-2A > T 11 years y y (tonic and atonic) PER, LAC, CLB, and RFM Ataxia, poor coordination, dystonia, hypertonus Able to walk No Autistic features, moderate–severe ID II IV III
14 DK f c.1061G > A
p. Cys354Tyr
13 years y y (currently seizure-free) None n/a n/a n/a n/a n/a n/a n/a

IT: Italy. NL: The Netherlands. DK: Denmark. Dev. delay: Developmental delay. GMFCS: Gross Motor Function Classification System. MACS: Manual Ability Classification System. CFCS: Communication Function Classification System. ASD: Autism spectrum disorder. CBD: Cannabidiol. CLB: clobazam. CBZ: carbamazepine. LAC: lacosamide. LEV: levetiracetam. LTG: lamotrigine. PB: phenobarbital. PER: perampanel. RFM: rufinamide. TPM: topiramate. VNS: Vagus nerve stimulation. VPA: valproic acid. Age in the table reflects the age at the time of the EEG recording.